What is the market price of olezarsen? What are the purchasing channels?
Olezarsen is an innovative drug targeting the treatment of familial chylomicronemia (FCS) and severe hypertriglyceridemia. It was officially approved for marketing in the United States in 2024 under the trade name Tryngolza. The drug is injected subcutaneously once every 4 weeks. According to official information, the annual treatment cost in the U.S. market is as high as approximately 59.5USD, which is approximately 4.30yen, indicating that it is positioned as a high-value drug for rare diseases and is suitable for specific high-risk patient groups.
From the price of a single dose, the price of 80mgmedicine solution required for each injection of Olezasen is more than 5 US dollars, which is equivalent to more than 35 yuan in RMB. The specific price will vary slightly depending on the pharmacy, insurance policy and payment method. Although it is expensive, the pharmaceutical company Ionis offers a patient support program called "Ionis Every Step", which may provide fee reductions or full funding for eligible US patients, significantly reducing the personal burden.

In terms of purchase channels, Olezason is currently only officially available in the United States and requires a prescription from a doctor and delivery through a specific authorized pharmacy or hospital. Its use must be carried out after evaluation by a professional doctor. Injections are generally arranged in specialized hospitals. Some patients can inject themselves at home after receiving training. There is currently no domestic listing information. If patients have any need for use, they can pay attention to overseas drug purchase, clinical trial recruitment or cross-border medical channels.
In addition to the United States, Olezacen is already in the approval or early access stage in countries and regions such as Europe, Canada, and Australia, and is expected to be launched in more countries in the future. For Chinese patients, they still need to obtain the drug through overseas channels, such as Hong Kong and Macao medical institutions or overseas pharmacies, but special attention must be paid to the formality of the source of the drug and compliant transportation. It is recommended that patients consult a professional doctor before taking medication and choose a treatment plan reasonably based on their own condition and financial ability.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)